A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/1997
11/06/1997	WO1997041120A1 Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
11/06/1997	WO1997041119A1 Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
11/06/1997	WO1997041103A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs
11/06/1997	WO1997041099A1 Azetidinone derivatives for the treatment of atherosclerosis
11/06/1997	WO1997041098A1 Azetidinone derivatives for the treatment of atherosclerosis
11/06/1997	WO1997041090A1 Inorganic ion receptor-active compounds
11/06/1997	WO1997040849A1 Method for treating or preventing ischemia-reperfusion injury
11/06/1997	WO1997040831A1 Therapeutic treatment for vegf related occular diseases
11/06/1997	WO1997040680A1 Antioxidant compound
11/06/1997	WO1997040679A1 Methods for delivering compounds into a cell
11/06/1997	WO1997033608A3 Antagonism of endothelin actions
11/06/1997	CA2253313A1 Method for treating or preventing ischemia-reperfusion injury
11/06/1997	CA2253282A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs
11/06/1997	CA2252696A1 Azetidinone derivatives for the treatment of atherosclerosis
11/06/1997	CA2252617A1 Methods for delivering compounds into a cell
11/06/1997	CA2250428A1 Plasmid-based vaccine for treating atherosclerosis
11/05/1997	EP0805158A2 Halo-substituted protein kinase C inhibitors
11/05/1997	EP0805147A1 Novel N-substituted alpha aminoacid amides as calcium channel modulators
11/05/1997	EP0804932A2 Contrast media for diagnostic imaging comprising gas filled microspeures
11/05/1997	EP0804601A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
11/05/1997	EP0804469A1 Novel peptide
11/05/1997	EP0804440A1 Tricyclic benzazepine vasopressin antagonists
11/05/1997	EP0804438A1 Tricyclic benzazepine vasopressin antagonists
11/05/1997	EP0804435A1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
11/05/1997	EP0804434A1 Azetidine, pyrrolidine and piperidine derivatives
11/05/1997	EP0804431A1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS
11/05/1997	EP0804430A1 Synthesis of optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic acids
11/05/1997	EP0804239A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
11/05/1997	EP0804229A2 Composition containing amlodipine, or a salt or felodipine and anace inhibitor
11/05/1997	EP0804198A1 An exercise hydration regimen to enhance exercise endurance and performance
11/05/1997	EP0804196A1 Use of serotonin antagonists (5ht 3?) for treating fibromyalgia
11/05/1997	EP0804192A1 Pharmaceutical preparations for tumour necrosis factor (tnf) inhibition
11/05/1997	EP0724584B1 Heterocyclic amines having central nervous system activity
11/05/1997	EP0636119B1 Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase
11/05/1997	CN1164230A Hypolipidemic benzothiazepines
11/05/1997	CN1163934A Protein with thrombocytopoietic factor active
11/05/1997	CN1163933A Protein with thrombocytopoietic factor active
11/05/1997	CN1163752A Chemical medicine composition for treating hypertension
11/05/1997	CN1036341C Process for preparing imidazole derivative
11/04/1997	US5684205 Use of substituted cyclopentane- di- and -triones
11/04/1997	US5684161 Process for preparing 1-substituted pyrrole-3-carboxylic acid derivatives
11/04/1997	US5684047 4-guanidinobutyramide for improving blood circulation
11/04/1997	US5684033 Antiarthritic agents, analgesics and migraine
11/04/1997	US5684030 2-substituted benzimidazole derivatives
11/04/1997	US5684028 Sulphorous derivatives of imidazole, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions
11/04/1997	US5684017 Antiarthritic agents, rheumatic diseases, antidiabetic agents for inhibiting interloeukins
11/04/1997	US5684015 Angiotensin antagonist as hypotensive agents and cardiovascular disorders
11/04/1997	US5684014 Cycloalkano-indole and -azaindole derivatives
11/04/1997	US5684012 Dimeric piperidine, tetrahydropyridine and piperazine derivatives
11/04/1997	US5684008 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
11/04/1997	US5684007 Methods for inhibiting cardiac fibroblast growth and cardiac fibrosis
11/04/1997	US5684005 Phenylpyrimidine compounds as inhibitors of excitatory amino acid glutamate
11/04/1997	US5684004 Antineoplastic agents, antiatherosclerotic agents, hypocholesterolemic agents
11/04/1997	US5683710 Percutaneous absorption preparation
11/04/1997	CA2083698C (+)-alpha-(2,3-dimethoxyphenyl)-1- [2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
11/04/1997	CA2025413C S-triazolo¬3,4-i\|purine derivatives
11/03/1997	CA2204082A1 Pharmaceutical compounds
10/1997
10/30/1997	WO1997040158A1 Epimorphin antagonist and process for producing the same
10/30/1997	WO1997040044A1 Heterocyclic compounds
10/30/1997	WO1997040043A1 Heterocyclic compounds
10/30/1997	WO1997040042A1 Heterocyclic compounds
10/30/1997	WO1997040028A1 Urea derivatives as inhibitors of impdh enzyme
10/30/1997	WO1997040016A1 Heterocyclic compounds
10/30/1997	WO1997006255A3 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
10/30/1997	CA2252527A1 Heterocyclic compounds
10/30/1997	CA2251974A1 Heterocyclic compounds
10/30/1997	CA2250873A1 Heterocyclic compounds
10/30/1997	CA2250472A1 Heterocyclic compounds
10/29/1997	EP0803505A1 Inhibitors of metalloproteases, process for their preparation and pharmaceutical compositions containing them
10/29/1997	EP0803503A1 Acids and esters of diosmetin and pharmaceutical compositions containing them
10/29/1997	EP0803501A1 Substituted guanidine derivatives and their use as Na+/H+ exchange inhibitors
10/29/1997	EP0802985A1 Cell cycle regulated repressor and dna element
10/29/1997	EP0802916A1 Low molecular weight bicyclic thrombin inhibitors
10/29/1997	EP0802910A1 Estrogen agonists/antagonists
10/29/1997	EP0802909A2 Substituted oxazolidine calpain and/or cathepsin b inhibitors
10/29/1997	EP0802908A1 Novel compounds
10/29/1997	EP0802900A1 Antiarrhythmic (s)-enantiomers of methanesulfonamides
10/29/1997	EP0802899A1 Enantiomers of 1-(3,4-dichlorobenzyl)-2-methylaminoindane
10/29/1997	EP0802897A1 Novel compounds
10/29/1997	EP0802797A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
10/29/1997	EP0802792A1 Therapeutic treatment for inhibiting vascular restenosis
10/29/1997	CN1163656A Axial flow valve system for linear compressor
10/29/1997	CN1163568A Use of 9-deoxy prostaglandin derivatives to treat glaucoma
10/29/1997	CN1163566A Quinazolinone pharmaceuticals and use thereof
10/29/1997	CN1163124A Decoction for curing cerebral vasscular diseases and its producing method
10/29/1997	CN1163122A Seabuckthorn fruit yolk health oil and its producing method
10/29/1997	CN1036265C Preparation of heterocyclic compounds
10/29/1997	CN1036263C Preparation of substituted azole
10/28/1997	US5681965 Alpha-phenyl tert-butyl nitrone and derivatives as free radical scavengers treating aging, oxidative tissue damage
10/28/1997	US5681961 Arylsulphonamides, pharmaceutical compositions containing these compounds and processes for preparing them
10/28/1997	US5681841 Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
10/28/1997	US5681835 Useful for treating osteoporosis
10/28/1997	US5681750 Process for preparing a C1-esterase inhibitor concentrate (C1-INH), and concentrate obtained, for therapeutic use
10/28/1997	US5681590 Dry mix formulation for bisphosphonic acids
10/28/1997	US5681582 Extended release, film-coated tablet of astemizole and pseudoephedrine
10/28/1997	US5681558 Method of using beta-interferons to treat restenosis
10/23/1997	WO1997039024A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/23/1997	WO1997039001A1 Isoxazolidine derivatives
10/23/1997	WO1997038991A1 Substituted tetracyclic tetrahydrofuran derivatives
10/23/1997	WO1997038986A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors

1 ... 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 ... 1595